We are live on ! Find out more
RG

Rathbones Group Portfolio holdings

AUM $27.1B
1-Year Est. Return 20.2%
This Fund
S&P 500
This Quarter Est. Return
+12.06%
1 Year Est. Return
+20.2%
3 Year Est. Return
+79.31%
5 Year Est. Return
+95.63%
10 Year Est. Return
+508.18%
AUM
$23.2B
AUM Growth
+$2.49B
Cap. Flow
+$467M
Cap. Flow %
2.01%
Top 10 Hldgs %
36.73%
Holding
646
New
43
Increased
209
Reduced
225
Closed
19

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$108M
2
META icon
Meta Platforms (Facebook)
META
+$64.4M
3
PH icon
Parker-Hannifin
PH
+$52M
4
MRSH
Marsh
MRSH
+$49.7M
5
MSI icon
Motorola Solutions
MSI
+$48.1M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$65.2M
2
EL icon
Estee Lauder
EL
+$49.3M
3
DIS icon
Walt Disney
DIS
+$44.4M
4
EW icon
Edwards Lifesciences
EW
+$37.2M
5
DXCM icon
DexCom
DXCM
+$31.1M

Sector Composition

Rank Sector Weight
1 Technology 27.32%
2 Financials 20.51%
3 Consumer Discretionary 11.26%
4 Healthcare 9.5%
5 Communication Services 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UUUU icon
451
Energy Fuels
UUUU
$2.86B
$420K ﹤0.01%
72,995
+25,575
+54% +$123K
SII
452
Sprott
SII
$2.66B
$418K ﹤0.01%
6,060
QAI icon
453
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.01B
$418K ﹤0.01%
12,919
+136
+1% +$4.28K
APA icon
454
APA Corp
APA
$13.2B
$413K ﹤0.01%
22,600
STWD icon
455
Starwood Property Trust
STWD
$5.92B
$411K ﹤0.01%
20,490
LVHI icon
456
Franklin International Low Volatility High Dividend Index ETF
LVHI
$5.35B
$407K ﹤0.01%
12,518
+95
+0.8% +$3.05K
MRNA icon
457
Moderna
MRNA
$21.8B
$403K ﹤0.01%
14,614
+5,019
+52% +$132K
HYLS icon
458
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.61B
$401K ﹤0.01%
9,595
LRCX icon
459
Lam Research
LRCX
$367B
$400K ﹤0.01%
4,110
IEF icon
460
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$399K ﹤0.01%
4,171
-8,904
-68% -$842K
BTG icon
461
B2Gold
BTG
$5B
$397K ﹤0.01%
109,937
+26,777
+32% +$87.9K
ING icon
462
ING
ING
$99.8B
$396K ﹤0.01%
18,100
-411
-2% -$8.3K
MXL icon
463
MaxLinear
MXL
$6.06B
$395K ﹤0.01%
27,820
+1,500
+6% +$17.3K
HPE icon
464
Hewlett Packard
HPE
$63.4B
$395K ﹤0.01%
19,323
-394
-2% -$6.61K
BOW
465
Bowhead Specialty Holdings
BOW
$1B
$394K ﹤0.01%
10,500
SU icon
466
Suncor Energy
SU
$79.4B
$391K ﹤0.01%
10,450
VBR icon
467
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$390K ﹤0.01%
2,000
PGR icon
468
Progressive
PGR
$123B
$390K ﹤0.01%
1,461
+25
+2% +$6.85K
DLN icon
469
WisdomTree US LargeCap Dividend Fund
DLN
$6.26B
$386K ﹤0.01%
4,700
CARR icon
470
Carrier Global
CARR
$51B
$385K ﹤0.01%
5,257
-1,664
-24% -$113K
VST icon
471
Vistra
VST
$50B
$373K ﹤0.01%
1,925
-80
-4% -$11.8K
CPRT icon
472
Copart
CPRT
$27B
$373K ﹤0.01%
7,600
-2,282
-23% -$128K
SCL icon
473
Stepan Co
SCL
$1.46B
$363K ﹤0.01%
6,650
RBLX icon
474
Roblox
RBLX
$25.4B
$358K ﹤0.01%
+3,405
New +$267K
HMY icon
475
Harmony Gold Mining
HMY
$9.84B
$358K ﹤0.01%
25,635
+5,089
+25% +$76.9K

Similar funds

Rathbones Group's Q2 2025 Portfolio in Review

As of Q2 2025, Rathbones Group held 646 positions worth $23.2B, up 12% from $20.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Rathbones Group's Q2 2025 filing shows 43 new, 209 increased, 225 reduced and 19 closed positions. Its largest new stake was Defi Technologies: 2,799,330 shares worth $8.79M. The largest sale was UnitedHealth, an estimated $65.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Rathbones Group's largest Q2 2025 buy was Defi Technologies: 2,799,330 shares worth $8.79M.
  • Rathbones Group added most to CRH in Q2 2025, an estimated $108M increase.
  • Rathbones Group's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $65.2M.
  • Rathbones Group fully exited Enphase Energy in Q2 2025, selling an estimated $1.7M.
  • Rathbones Group's ten largest holdings make up 37% of its $23.2B portfolio in Q2 2025.
  • Rathbones Group opened 43 new positions and closed 19 in Q2 2025.
  • Rathbones Group's portfolio value rose 12% quarter-over-quarter to $23.2B.

Based on Rathbones Group's 13F filing for Q2 2025, filed 7 Aug 2025.